X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.clinicaltrialsarena.com/news/fda-interna-phase-i-solid-tumour/
https://www.businesswire.com/news/home/20210324005075/en/InteRNA-Technologies-Publishes-Preclinical-Data-from-Investigational-microRNA-INT-1B3-Program-in-Molecular-Therapy-%E2%80%93-Nucleic-Acids-and-Oncotarget
https://www.businesswire.com/news/home/20210311005064/en/InteRNA-Technologies-Awarded-%E2%82%AC-2.7M-Clinical-Innovation-Credit-from-Dutch-Government
https://www.clinicaltrialsarena.com/news/interna-technologies-dosing-trial/
https://www.businesswire.com/news/home/20210216005539/en/InteRNA-Technologies-Announces-Dosing-of-First-Patient-in-First-in-Human-Trial-of-microRNA-Drug-Candidate-INT-1B3-in-Patients-with-Advanced-Solid-Tumors
Market Place
Share 
